LinkedIn·Tuesday, 16 June 2026·16 Jun 2026
Pleased to see the publication of the RADIAL (Trials@Home) study, sharing important insights on the implementation of decentralized…
Bernard Vrijens
Chief Executive Officer & Scientific Lead | Honorary Member of the International Society for Medication Adherence | Exposure-informed clinical trials.
Pleased to see the publication of the RADIAL (Trials@Home) study, sharing important insights on the implementation of decentralized clinical trials across Europe.
In this pioneering initiative, AARDEX Group contributed its adherence monitoring platform to support robust and accurate measurement of treatment exposure in a decentralized setting.
Congratulations to the Trials@Home team and all collaborators involved in this important work.
View on LinkedIn Cross-referenced
Related on the wire
If Netflix can track every click, #ClinicalTrials should be able to track every dose.
AI applied to 1980s endpoints" has a close cousin: precision therapeutics evaluated with imprecise exposure measurement. We routinely ask…
Is the geography of clinical trials creating a new hidden risk for drug development? For decades, Europe has been a reliable region for…
A very good Forbes article highlighting a critical challenge in clinical research: medication nonadherence remains one of the largest…